Trebananib Completed Phase 2 Trials for Adult Angiosarcoma / Recurrent Adult Soft Tissue Sarcoma / Stage III Adult Soft Tissue Sarcoma / Stage IV Adult Soft Tissue Sarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01623869Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery